Investigating the role of a protein in pancreatic cancer development
Official title: Role of Gastrokine 2 in pancreatic cancer development
Funded at Univ of North Carolina Chapel Hill · NIH-10884874 · Data updated 2026-11-12
This study is looking at a protein called Gastrokine 2 that is usually found in the stomach, to see how it might affect the growth of pancreatic cancer, with the hope of finding new ways to help people with this type of cancer.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | July 12, 2023 |
| Project end | July 11, 2025 |
| Funding year | 2024 |
| Award (this year) | $40,491 |
| NIH project number | 5F31CA278589-02 |
| Project ID | NIH-10884874 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma or those at high risk for developing this type of cancer.
✕Less likely to help
Patients with other types of cancer or those without pancreatic cancer risk factors may not benefit from this research.
What this research studies
This research focuses on understanding how Gastrokine 2 (Gkn2), a protein normally found in stomach cells, may influence the development of pancreatic cancer. Researchers will explore how Gkn2 expression changes in pancreatic cancer cells and its potential role in cancer progression. By examining the mechanisms behind Gkn2's involvement, the study aims to uncover new insights that could lead to better treatment strategies for pancreatic cancer patients.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic targets for pancreatic cancer, potentially improving survival rates.
How similar studies have gone: While the role of Gastrokine 2 in pancreatic cancer is still being explored, similar studies on other proteins have shown promise in understanding cancer mechanisms and developing new treatments.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Bell, Whitney Jean — Univ of North Carolina Chapel Hill
- Study coordinator: Bell, Whitney Jean
Related research
Other NIH-funded projects on the same topics.
-
Microbial Dysbiosis and Its Role in Pancreatic Cancer
A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.
-
Targeting aberrant enhancer landscapes in pancreatic cancer
A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.
-
Exosome-based microRNA biomarkers for early, non-invasive detection of pancreatic cancer
A study to develop a blood test that uses tiny RNA signals in exosomes to detect pancreatic cancer early, aiming to help people at risk or with early disease.
-
Exosome-based microRNA biomarkers for early detection of pancreatic cancer
A patient-friendly look at a study using tiny blood-based RNA markers inside exosomes to catch pancreatic cancer early without invasive procedures.
-
Programmable implanted living materials to fight pancreatic cancer
A patient-facing program will explore a safe, implantable living material that delivers sequential immunotherapies directly to pancreatic tumors to help fight cancer.
-
Targeting how platelets and pancreatic cancer talk to each other
A study exploring whether blocking the interaction between platelets and pancreatic cancer cells could slow cancer growth and spread and help identify new biomarkers.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.